Tag: Spyral Symplicity
Money-maker or meritable: Is renal denervation out of retirement?
In a paper published in the July 2024 issue of the Journal of Hypertension, Andrew Sharp (University...
AHA 2022: SPYRAL HTN-ON MED study demonstrates “meaningful clinical benefits” consistent with other renal denervation trials
Medtronic has announced the six-month results from the full cohort of the SPYRAL HTN-ON MED clin...
From SYMPLICITY HTN-1 to SPYRAL HTN-OFF MED: The story of renal denervation
It is now almost a decade since the first patient underwent catheter-based renal denervation as ...
ESC 2017: SPYRAL HTN-OFF MED provides “proof of principle” that renal denervation works
Results from SPYRAL HTN-OFF MED indicate that renal denervation, compared with a sham procedure,...
